Dr. Evan Michael Lapinsky, MD

  • Newark, DE
  • Hematologist and oncologist
NPI1134486046PAC ID0143443499
Medicare services, 2024
61,748
Medicare patients, 2024
615
Part D claims, 2024
977
Publications
2
MIPS score, 2024
100
Practice address
4701 Ogletown Stanton Rd, Newark, DE 19713
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Pathology Hematology Hgcc - HOPD

Acute Care Hospital outpatient department · Newark, Delaware

See all 6 affiliations

Find Dr. Lapinsky's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Evan Michael Lapinsky is a hematologist and oncologist in Newark, Delaware

Dr. Lapinsky practices at Pathology Hematology Hgcc - HOPD in Newark, Delaware.

Dr. Lapinsky's NPI, 1134486046, was assigned on April 16, 2012. Dr. Lapinsky graduated from Jefferson Medical College of Thomas Jefferson University in 2019. Dr. Lapinsky holds Delaware license C1-0013028.

NPI and contact details
Medicare PAC ID
0143443499
NPI enumeration date
April 16, 2012
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
33
Medical school graduation
2019

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Evan Michael Lapinsky practices at Pathology Hematology Hgcc - HOPD in Newark, Delaware

Dr. Lapinsky's primary practice is Pathology Hematology Hgcc - HOPD, at 4701 Ogletown Stanton Rd, Newark, DE 19713.

  • Pathology Hematology Hgcc - HOPD
    4701 Ogletown Stanton Rd, Newark, DE 19713

Source: Dmand AI Affiliation Data

Dr. Evan Michael Lapinsky is affiliated with 5 sites of care and 1 medical group

Dr. Lapinsky's primary practice is Pathology Hematology Hgcc - HOPD in Newark, Delaware. Dr. Lapinsky is also affiliated with Christiana Hospital. The medical group on file is Medical Oncology Hematology Consultants, PA. Dmand AI also links Dr. Lapinsky to 2 more hospitals and 1 group practice or clinic, each named with a free account. Dr. Lapinsky's employer is on file too: a hospital.

See all 6 affiliations for Dr. Lapinsky

Source: Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Evan Michael Lapinsky's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lapinsky practices, 5 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Pathology Hematology Hgcc - HOPDAvailable with a free account
+4 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Lapinsky practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Evan Michael Lapinsky is one of 42 hematologists and oncologists in Delaware

Hematology and oncology is Dr. Lapinsky's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Lapinsky's licenses on file in 2 states: Delaware and Pennsylvania.

Specialties and state licenses

  • Hematology and oncology, DelawarePrimaryLicense C1-0013028 · taxonomy 207RH0003X
  • Internal medicine, PennsylvaniaLicense MD453456 · taxonomy 207R00000X

Hematologists and oncologists near Dr. Lapinsky

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Evan Michael Lapinsky billed Medicare for 61,748 services in 2024

CMS data shows 61,748 Medicare services from Dr. Lapinsky across 45 procedure codes in 2024, for 615 Medicare patients. Medicare paid $1,479,990 for them.

Medicare services, 202461,748
Medicare patients615
Paid by Medicare$1.5M
Procedure codes45

Dr. Lapinsky's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Drugs given in the office
2023: 58,1432024: 58,6061%
Tests and treatments
2023: 1,7812024: 2,03614%
Office and hospital visits
2023: 9232024: 9412%
Other services
2023: 3682024: 15458%
Surgery
2023: 292024: 1162%

Where Dr. Lapinsky's Medicare services took place, 2024

  • In an office61,642100%
  • In a facility1060%

Dr. Lapinsky compared with the Delaware median for hematologists and oncologists, 2024

  • Dr. Lapinsky
  • Delaware median
Medicare services
61,748vs 81076.2 times
Medicare patients
615vs 41150% above
Part D claims
744vs 59625% above

Medians across 40 hematologists and oncologists in Delaware with Dmand AI profiles that report each measure.

Dr. Lapinsky's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Lapinsky

Need commercial claims for Dr. Lapinsky?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Lapinsky and other hematologists and oncologists in Delaware.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Evan Michael Lapinsky treated 615 Medicare patients in 2024, average age 76

CMS counts 615 Medicare patients who saw Dr. Lapinsky in 2024. The largest group is 75 to 84, with 269 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lapinsky's median patient age at 71, with 50% women.

Medicare patients, 2024615
Average age76
Average risk score1.98
Also on Medicaid9%

Dr. Lapinsky's Medicare patients by age, 2024

Dr. Lapinsky's Medicare patients by sex, 2024

  • Women30550%
  • Men31050%

Chronic conditions among Dr. Lapinsky's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Arthritis53%
  4. Cancer46%
  5. Diabetes34%
  6. Chronic kidney disease32%
  7. Ischemic heart disease29%
  8. Mood disorders27%

Share of Medicare patients with each condition. A patient can have several.

Dr. Lapinsky's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 71

Patient panel by sex, all payers

  • Women50%
  • Men47%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Evan Michael Lapinsky wrote 977 Medicare Part D claims in 2024

In 2024, Dr. Lapinsky wrote 977 Medicare Part D claims for 202 patients. 75% of them were for generic drugs. CMS names the drug for 744 of them, across 24 drugs with 11 or more claims each, at $1,206,070 in total drug cost. In 2023, CMS named 610 claims across 20 drugs.

Part D claims, 2024977
Drugs named by CMS24
Total drug cost$1.2M
Part D patients202

Dr. Lapinsky's Part D claims by kind of drug, 2024

  • Generic734 claims75%
  • Brand-name and other243 claims25%

Dr. Lapinsky's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Lapinsky's Part D claims, 2024

  • Opioids8%74 of 977 claims
  • Antibiotics3%28 of 977 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 6102024: 74422%

Drugs named by CMS: 24 in 2024, 20 in 2023.

See all prescribing by Dr. Lapinsky

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Evan Michael Lapinsky scored 100 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Lapinsky for performance year 2024, reported individually. Dr. Lapinsky accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lapinsky as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Lapinsky's MIPS scores, performance year 2024

  • 100of 100Final score
  • 100of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Lapinsky by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Evan Michael Lapinsky has 2 publications on record

Dmand AI links 2 papers to Dr. Lapinsky in 2019. 2019 was the busiest year, with 2. Dr. Lapinsky's most frequent co-authors are Andrew E. Chapman, DO, Lillian Man, MD and Sheel Rajoo Patel, MD.

Papers2

Dr. Lapinsky's most frequent co-authors

Recent publications by Dr. Lapinsky

See all 2 publications and co-authors

See who Dr. Lapinsky researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Lapinsky works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Evan Michael Lapinsky received $1,658 in industry payments from 2017 to 2025

CMS Open Payments shows 83 general payments to Dr. Lapinsky from 32 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 94% of the total. AstraZeneca Pharmaceuticals LP paid the most, $267.

General payments to Dr. Lapinsky by program year, 2017 to 2025

General payments to Dr. Lapinsky by kind, 2017 to 2025

$1.7Kin total
  • Food and beverage$1,55894%
  • Education$996%

Companies that paid Dr. Lapinsky the most, 2017 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Lapinsky

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Evan Michael Lapinsky graduated from Jefferson Medical College of Thomas Jefferson University

Dr. Lapinsky graduated from Jefferson Medical College of Thomas Jefferson University in 2019.

  1. Medical schoolJefferson Medical College of Thomas Jefferson University

Source: Dmand AI Professional Profile Data

Sources for Dr. Evan Michael Lapinsky's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Evan Michael Lapinsky

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Evan Michael Lapinsky's NPI number?

Dr. Evan Michael Lapinsky's NPI number is 1134486046. It was assigned on April 16, 2012, and it is active in the NPI Registry.

What kind of doctor is Dr. Evan Michael Lapinsky?

Dr. Evan Michael Lapinsky is a hematologist and oncologist in Newark, Delaware. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Evan Michael Lapinsky practice?

Dr. Lapinsky practices at 4701 Ogletown Stanton Rd, Newark, DE 19713. Dr. Lapinsky's primary practice is Pathology Hematology Hgcc - HOPD in Newark, Delaware. Dmand AI also links Dr. Lapinsky to 2 hospitals and 1 group practice or clinic.

What is Dr. Evan Michael Lapinsky's medical license number?

Dr. Lapinsky holds Delaware license C1-0013028, one of the licenses on file in 2 states.

Which states has Dr. Evan Michael Lapinsky been licensed in?

Dmand AI has state licenses on file for Dr. Lapinsky in Delaware and Pennsylvania.

Which hospitals is Dr. Evan Michael Lapinsky affiliated with?

Dr. Lapinsky is affiliated with Christiana Hospital. Dmand AI links Dr. Lapinsky to 2 more hospitals.

What medical group is Dr. Evan Michael Lapinsky part of?

Dr. Lapinsky is linked to Medical Oncology Hematology Consultants, PA.

Does Dr. Evan Michael Lapinsky accept Medicare?

Yes. CMS data shows Dr. Lapinsky billed Medicare for 61,748 services in 2024, and Dr. Lapinsky accepts Medicare assignment.

Does Dr. Evan Michael Lapinsky offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Lapinsky as offering telehealth services.

What is Dr. Evan Michael Lapinsky's MIPS score?

Dr. Lapinsky's MIPS final score for performance year 2024 is 100 out of 100, reported individually.

Show 8 more questionsShow fewer questions

How many Medicare patients does Dr. Evan Michael Lapinsky see?

CMS counts 615 Medicare patients who saw Dr. Lapinsky in 2024, with an average age of 76.

What services does Dr. Evan Michael Lapinsky bill to Medicare?

In 2024, Dr. Lapinsky's most billed Medicare services were injected or infused drug (J9263), injected or infused drug (J9144) and injected or infused drug (J9271).

Where did Dr. Evan Michael Lapinsky go to medical school?

Dr. Lapinsky graduated from Jefferson Medical College of Thomas Jefferson University in 2019.

What drugs does Dr. Evan Michael Lapinsky prescribe most?

In 2024 Medicare Part D data, Dr. Lapinsky's most prescribed drugs by claims were Anastrozole, Eliquis and Ondansetron HCl.

Has Dr. Evan Michael Lapinsky received payments from drug or device companies?

CMS Open Payments shows $1,658 in general payments to Dr. Lapinsky from 32 companies from 2017 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.

How long has Dr. Evan Michael Lapinsky been practicing?

Dr. Lapinsky graduated from medical school in 2019, 7 years ago.

Does Dr. Evan Michael Lapinsky do research?

Dmand AI links 2 publications to Dr. Lapinsky.

Who does Dr. Evan Michael Lapinsky publish with?

Dr. Lapinsky's most frequent co-authors are Andrew E. Chapman, DO (1 shared paper), Lillian Man, MD (1 shared paper) and Sheel Rajoo Patel, MD (1 shared paper).

Selling to hematology and oncology practices?

See hematologists and oncologists in Delaware by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)